The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies - PubMed (original) (raw)
Comparative Study
. 2000 Apr 14;288(5464):339-44.
doi: 10.1126/science.288.5464.339.
A Shimoda, A Coiana, G Diaz, G Peddis, J C Melpolder, A Strazzera, D Y Chien, S J Munoz, A Balestrieri, R H Purcell, H J Alter
Affiliations
- PMID: 10764648
- DOI: 10.1126/science.288.5464.339
Comparative Study
The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies
P Farci et al. Science. 2000.
Abstract
The mechanisms by which hepatitis C virus (HCV) induces chronic infection in the vast majority of infected individuals are unknown. Sequences within the HCV E1 and E2 envelope genes were analyzed during the acute phase of hepatitis C in 12 patients with different clinical outcomes. Acute resolving hepatitis was associated with relative evolutionary stasis of the heterogeneous viral population (quasispecies), whereas progressing hepatitis correlated with genetic evolution of HCV. Consistent with the hypothesis of selective pressure by the host immune system, the sequence changes occurred almost exclusively within the hypervariable region 1 of the E2 gene and were temporally correlated with antibody seroconversion. These data indicate that the evolutionary dynamics of the HCV quasispecies during the acute phase of hepatitis C predict whether the infection will resolve or become chronic.
Similar articles
- A Novel Approach To Display Structural Proteins of Hepatitis C Virus Quasispecies in Patients Reveals a Key Role of E2 HVR1 in Viral Evolution.
Tong Y, Li Q, Li R, Xu Y, Pan Y, Niu J, Zhong J. Tong Y, et al. J Virol. 2020 Aug 17;94(17):e00622-20. doi: 10.1128/JVI.00622-20. Print 2020 Aug 17. J Virol. 2020. PMID: 32554700 Free PMC article. - Acceleration of hepatitis C virus envelope evolution in humans is consistent with progressive humoral immune selection during the transition from acute to chronic infection.
Liu L, Fisher BE, Dowd KA, Astemborski J, Cox AL, Ray SC. Liu L, et al. J Virol. 2010 May;84(10):5067-77. doi: 10.1128/JVI.02265-09. Epub 2010 Mar 3. J Virol. 2010. PMID: 20200239 Free PMC article. - [Physiopathology of HCV infection].
Zarski JP, Souvignet C. Zarski JP, et al. Gastroenterol Clin Biol. 2002 Apr;26 Spec No 2:B154-62. Gastroenterol Clin Biol. 2002. PMID: 12180283 Review. French. No abstract available. - Hepatitis C virus population dynamics during infection.
Pawlotsky JM. Pawlotsky JM. Curr Top Microbiol Immunol. 2006;299:261-84. doi: 10.1007/3-540-26397-7_9. Curr Top Microbiol Immunol. 2006. PMID: 16568902 Review.
Cited by
- Genetic Variability of Hepatitis C Virus (HCV) 5' Untranslated Region in HIV/HCV Coinfected Patients Treated with Pegylated Interferon and Ribavirin.
Bukowska-Ośko I, Pawełczyk A, Perlejewski K, Kubisa N, Caraballo Cortés K, Rosińska M, Płoski R, Fic M, Kaźmierczak J, Popiel M, Ząbek P, Horban A, Radkowski M, Laskus T. Bukowska-Ośko I, et al. PLoS One. 2015 May 1;10(5):e0125604. doi: 10.1371/journal.pone.0125604. eCollection 2015. PLoS One. 2015. PMID: 25932941 Free PMC article. - Three different functional microdomains in the hepatitis C virus hypervariable region 1 (HVR1) mediate entry and immune evasion.
Guan M, Wang W, Liu X, Tong Y, Liu Y, Ren H, Zhu S, Dubuisson J, Baumert TF, Zhu Y, Peng H, Aurelian L, Zhao P, Qi Z. Guan M, et al. J Biol Chem. 2012 Oct 12;287(42):35631-35645. doi: 10.1074/jbc.M112.382341. Epub 2012 Aug 27. J Biol Chem. 2012. PMID: 22927442 Free PMC article. - The evolution of the major hepatitis C genotypes correlates with clinical response to interferon therapy.
Pang PS, Planet PJ, Glenn JS. Pang PS, et al. PLoS One. 2009 Aug 11;4(8):e6579. doi: 10.1371/journal.pone.0006579. PLoS One. 2009. PMID: 19668364 Free PMC article. - Arenavirus diversity and evolution: quasispecies in vivo.
Sevilla N, de la Torre JC. Sevilla N, et al. Curr Top Microbiol Immunol. 2006;299:315-35. doi: 10.1007/3-540-26397-7_11. Curr Top Microbiol Immunol. 2006. PMID: 16568904 Free PMC article. Review. - Influence of increased CD4 cell counts on the genetic variability of hepatitis C virus in patients co-infected with human immunodeficiency virus I.
Wang XP, Goodwin L, Kahn P, Gawel C, Cunha CB, Laser B, Sahn B, Kaplan MH. Wang XP, et al. J Biomol Tech. 2006 Jul;17(3):228-39. J Biomol Tech. 2006. PMID: 16870714 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases